Livia Viganor1, Anna Clara M Galdino2, Ana Paula F Nunes3, Kátia R N Santos4, Marta H Branquinha5, Michael Devereux6, Andrew Kellett7, Malachy McCann8, André L S Santos9. 1. General Microbiology Department, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil The Inorganic Pharmaceutical and Biomimetic Research Centre, Focas Research Institute, Dublin Institute of Technology, Dublin, Ireland. 2. General Microbiology Department, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Biochemistry Post-Graduation Programme, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 3. Pathology Department and Infection Diseases Post-Graduation Programme, Federal University of Espírito Santo, Espírito Santo, Brazil. 4. Medical Microbiology Department, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 5. General Microbiology Department, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 6. The Inorganic Pharmaceutical and Biomimetic Research Centre, Focas Research Institute, Dublin Institute of Technology, Dublin, Ireland. 7. School of Chemical Sciences and the National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. 8. Chemistry Department, Maynooth University, National University of Ireland, Maynooth, Ireland. 9. General Microbiology Department, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil The Inorganic Pharmaceutical and Biomimetic Research Centre, Focas Research Institute, Dublin Institute of Technology, Dublin, Ireland andre@micro.ufrj.br.
Abstract
OBJECTIVES: The beneficial antimicrobial properties of 1,10-phenanthroline (phen)-based drugs, together with the imperative need to develop new chemotherapeutic options for prevention/treatment of infections caused by MDR Gram-negative bacteria, led us to evaluate the effects of phen, 1,10-phenanthroline-5,6-dione (phendione), [Ag(phendione)2]ClO4 and [Cu(phendione)3](ClO4)2·4H2O on planktonic- and biofilm-growing Pseudomonas aeruginosa. METHODS: Thirty-two non-duplicated Brazilian clinical isolates of P. aeruginosa with distinct genetic backgrounds were used in all experiments. The effect of test compounds on planktonic bacterial proliferation was determined as recommended by CLSI protocol. The effect on biofilm formation was evaluated by crystal violet incorporation (biomass determination) and XTT (viability assay). Mature biofilm disorganization was evidenced by staining with crystal violet. RESULTS: Phen-based compounds presented anti-P. aeruginosa activity, but with different potencies concerning the geometric mean MIC: [Cu(phendione)3](2+) (7.76 μM) > [Ag(phendione)2](+) (14.05 μM) > phendione (31.15 μM) > phen (579.28 μM). MICs of each compound were similar irrespective of whether the P. aeruginosa isolates were susceptible or resistant to classical antimicrobials (ceftazidime, meropenem and imipenem). The pretreatment of bacteria with phen, phendione and phendione's metal derivatives at 0.5 × MIC value inhibited biofilm formation, particularly the use of [Cu(phendione)3](2+) and [Ag(phendione)2](+), which significantly reduced both biomass (48% and 44%, respectively) and viability (78% and 77%, respectively). The compounds studied also disrupted mature biofilm in a dose-dependent manner, especially [Ag(phendione)2](+) and [Cu(phendione)3](2+) (IC50, 9.39 and 10.16 μM, respectively). CONCLUSIONS: Coordination of phendione to Ag(+) and Cu(2+) represents a new promising group of anti-infective agents, which revealed a potent anti-P. aeruginosa action against both planktonic- and biofilm-growing cells.
OBJECTIVES: The beneficial antimicrobial properties of 1,10-phenanthroline (phen)-based drugs, together with the imperative need to develop new chemotherapeutic options for prevention/treatment of infections caused by MDR Gram-negative bacteria, led us to evaluate the effects of phen, 1,10-phenanthroline-5,6-dione (phendione), [Ag(phendione)2]ClO4 and [Cu(phendione)3](ClO4)2·4H2O on planktonic- and biofilm-growing Pseudomonas aeruginosa. METHODS: Thirty-two non-duplicated Brazilian clinical isolates of P. aeruginosa with distinct genetic backgrounds were used in all experiments. The effect of test compounds on planktonic bacterial proliferation was determined as recommended by CLSI protocol. The effect on biofilm formation was evaluated by crystal violet incorporation (biomass determination) and XTT (viability assay). Mature biofilm disorganization was evidenced by staining with crystal violet. RESULTS:Phen-based compounds presented anti-P. aeruginosa activity, but with different potencies concerning the geometric mean MIC: [Cu(phendione)3](2+) (7.76 μM) > [Ag(phendione)2](+) (14.05 μM) > phendione (31.15 μM) > phen (579.28 μM). MICs of each compound were similar irrespective of whether the P. aeruginosa isolates were susceptible or resistant to classical antimicrobials (ceftazidime, meropenem and imipenem). The pretreatment of bacteria with phen, phendione and phendione's metal derivatives at 0.5 × MIC value inhibited biofilm formation, particularly the use of [Cu(phendione)3](2+) and [Ag(phendione)2](+), which significantly reduced both biomass (48% and 44%, respectively) and viability (78% and 77%, respectively). The compounds studied also disrupted mature biofilm in a dose-dependent manner, especially [Ag(phendione)2](+) and [Cu(phendione)3](2+) (IC50, 9.39 and 10.16 μM, respectively). CONCLUSIONS: Coordination of phendione to Ag(+) and Cu(2+) represents a new promising group of anti-infective agents, which revealed a potent anti-P. aeruginosa action against both planktonic- and biofilm-growing cells.
Authors: I Milionis; C N Banti; I Sainis; C P Raptopoulou; V Psycharis; N Kourkoumelis; S K Hadjikakou Journal: J Biol Inorg Chem Date: 2018-04-13 Impact factor: 3.358
Authors: Roberta F Ventura; Anna Clara M Galdino; Livia Viganor; Ricardo P Schuenck; Michael Devereux; Malachy McCann; André L S Santos; Ana Paula F Nunes Journal: Braz J Microbiol Date: 2020-07-31 Impact factor: 2.476
Authors: Ana Karina C Lima; Camila G R Elias; Simone S C Oliveira; Jacenir R Santos-Mallet; Malachy McCann; Michael Devereux; Marta H Branquinha; Patrícia M L Dutra; André L S Santos Journal: Parasitol Res Date: 2021-08-07 Impact factor: 2.289
Authors: Marcela Queiroz Granato; Diego de Souza Gonçalves; Sergio Henrique Seabra; Malachy McCann; Michael Devereux; André Luis Souza Dos Santos; Lucimar Ferreira Kneipp Journal: Front Microbiol Date: 2017-01-30 Impact factor: 5.640
Authors: Anna Clara M Galdino; Lívia Viganor; Alexandre A de Castro; Elaine F F da Cunha; Thaís P Mello; Larissa M Mattos; Marcos D Pereira; Mary C Hunt; Megan O'Shaughnessy; Orla Howe; Michael Devereux; Malachy McCann; Teodorico C Ramalho; Marta H Branquinha; André L S Santos Journal: Front Microbiol Date: 2019-08-02 Impact factor: 5.640
Authors: Anna Clara Milesi Galdino; Lívia Viganor; Andrew Kellett; André Luis Souza Dos Santos; Matheus Mendonça Pereira; Michael Devereux; Malachy McCann; Marta Helena Branquinha; Zara Molphy; Sinéad O'Carroll; Conor Bain; Georgia Menounou Journal: J Biol Inorg Chem Date: 2022-01-10 Impact factor: 3.358